XML 42 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Operating activities:      
Net loss $ (8,333,000) $ (6,038,000) $ (4,404,000)
Adjustments to reconcile net loss to net cash provided by operating activities:      
(Gain) loss on interest rate swap (328,000) 42,000 (343,000)
Depreciation and amortization 47,439,000 19,505,000 6,889,000
Amortization of deferred rent (450,000) (61,000) 71,000
Share-based compensation 7,834,000 1,816,000 218,000
Excess tax benefit related to share-based compensation   (974,000)  
Provision for doubtful accounts 2,297,000 173,000 226,000
Amortization of deferred financing costs 1,941,000 872,000 132,000
Loss on early extinguishment of debt 621,000 3,169,000 461,000
Deferred income taxes (6,364,000) (5,406,000) (2,723,000)
Other     10,000
Changes in operating assets and liabilities, net of effects of acquisitions:      
Accounts receivable (9,047,000) (2,098,000) (1,100,000)
Prepaid expenses and other current assets (1,801,000) 560,000 141,000
Accounts payable and accrued expenses (1,907,000) 5,946,000 2,982,000
Accrued interest expense 10,240,000   59,000
Deferred revenue and customer deposits (169,000) (917,000) (270,000)
Other liabilities (2,430,000) 1,714,000 1,828,000
Net cash provided by operating activities 39,543,000 18,303,000 4,177,000
Investing activities:      
Cash paid for acquisitions, net (322,248,000) (115,225,000) (25,707,000)
Purchases of equipment and leasehold improvements (6,856,000) (1,730,000) (1,559,000)
Working capital and other settlements for acquisitions (6,710,000) 418,000 1,491,000
Net cash used in investing activities (335,814,000) (116,537,000) (25,775,000)
Financing activities:      
Borrowings under credit facilities 278,000,000 67,315,000 40,134,000
Borrowings under senior unsecured notes payable 250,000,000    
Net borrowings under working capital facilities 35,621,000 4,997,000  
Proceeds from the exercise of options and warrants 2,292,000 703,000  
Excess tax benefit related to share-based compensation   974,000  
Issuance of preferred stock, net   32,421,000  
Issuance of common stock, net   136,660,000 560,000
Advances (repayments) from related party notes   (3,500,000) 3,500,000
Repayment of subordinated unsecured notes payable (2,421,000) (2,167,000) (345,000)
Purchases of stock for treasury (9,421,000)    
Payment of deferred financing costs (9,746,000) (6,534,000) (1,817,000)
Repayment under credit facilities (273,000,000) (100,550,000) (20,138,000)
Other (440,000)    
Net cash provided by financing activities 270,885,000 130,319,000 21,894,000
Exchange rate impact on cash and cash equivalents 178,000 40,000  
Net increase (decrease) in cash and cash equivalents (25,208,000) 32,125,000 296,000
Cash and cash equivalents, beginning of year 33,624,000 1,499,000 1,203,000
Cash and cash equivalents, end of year 8,416,000 33,624,000 1,499,000
Supplemental disclosure of noncash investing and financing activities:      
Issuance of subordinated unsecured notes payable for acquisitions   1,747,000 5,512,000
Issuance of deferred payments for acquisitions     389,000
Issuance of common stock to settle earnout obligations 808,000 576,000  
Issuance of common stock for termination of agreement   1,434,000  
Supplemental disclosures of cash flow information:      
Cash paid for interest 5,447,000 4,994,000 1,332,000
Cash paid for income taxes 4,061,000 231,000 207,000
Issuance Of Common Stock For Acquisitions [Member]
     
Supplemental disclosure of noncash investing and financing activities:      
Issuance of common stock for acquisitions $ 47,174,000 $ 10,075,000 $ 3,503,000